[go: up one dir, main page]

NO3034071T3 - - Google Patents

Info

Publication number
NO3034071T3
NO3034071T3 NO15193269A NO15193269A NO3034071T3 NO 3034071 T3 NO3034071 T3 NO 3034071T3 NO 15193269 A NO15193269 A NO 15193269A NO 15193269 A NO15193269 A NO 15193269A NO 3034071 T3 NO3034071 T3 NO 3034071T3
Authority
NO
Norway
Application number
NO15193269A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO3034071(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO3034071T3 publication Critical patent/NO3034071T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Edible Oils And Fats (AREA)
NO15193269A 2011-12-21 2012-12-19 NO3034071T3 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11195015 2011-12-21
EP12185714 2012-09-24
EP15193269.6A EP3034071B1 (fr) 2011-12-21 2012-12-19 Nouvelle combinaison
EP12813324.6A EP2793866B2 (fr) 2011-12-21 2012-12-19 Comprimé bicouche comprenant du chlorhydrate de bénazépril et du pimobendane

Publications (1)

Publication Number Publication Date
NO3034071T3 true NO3034071T3 (fr) 2018-05-05

Family

ID=47552987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15193269A NO3034071T3 (fr) 2011-12-21 2012-12-19

Country Status (22)

Country Link
US (1) US10874618B2 (fr)
EP (3) EP2793866B2 (fr)
JP (1) JP6148252B2 (fr)
CN (1) CN104010632B (fr)
AU (1) AU2012357795B2 (fr)
BR (1) BR112014014896A2 (fr)
CA (1) CA2858941C (fr)
CL (1) CL2014001534A1 (fr)
CO (1) CO6970601A2 (fr)
CY (1) CY1117086T1 (fr)
DK (2) DK3034071T3 (fr)
ES (2) ES2656412T3 (fr)
HR (1) HRP20151347T1 (fr)
HU (2) HUE035830T2 (fr)
MX (1) MX365621B (fr)
NO (1) NO3034071T3 (fr)
PL (2) PL2793866T5 (fr)
PT (1) PT3034071T (fr)
RS (1) RS54475B1 (fr)
RU (1) RU2014129508A (fr)
SI (1) SI2793866T1 (fr)
WO (1) WO2013092673A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
EP2793866B2 (fr) 2011-12-21 2023-10-25 Elanco Tiergesundheit AG Comprimé bicouche comprenant du chlorhydrate de bénazépril et du pimobendane
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
ES2860526T3 (es) 2013-07-19 2021-10-05 Boehringer Ingelheim Vetmedica Gmbh Derivados de ciclodextrina eterificada conservados que contienen una composición farmacéutica acuosa líquida
KR102308973B1 (ko) 2013-12-04 2021-10-08 베링거잉겔하임베트메디카게엠베하 개선된 피모벤단의 약제학적 조성물
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN112618505B (zh) * 2020-12-30 2022-11-15 南京朗博特动物药业有限公司 一种宠物用含有贝那普利和匹莫苯丹的复方药物组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364646A (en) 1990-01-10 1994-11-15 Dr. Karl Thomae Gmbh Oral pharmaceutical forms of pimobendan
US6162802A (en) 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
CA2432638A1 (fr) 2000-12-18 2002-06-27 Novartis Ag Combinaison therapeutique d'amlodipine et de benazepril
WO2003075842A2 (fr) 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Formulations stables d'inhibiteurs de l'enzyme de conversion de l'angiotensine (ace)
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
KR20060120126A (ko) 2003-10-20 2006-11-24 노파르티스 아게 심혈관계 이환상태를 감소시키기 위한 베나제프릴 및암로디핀
GB2394660A (en) 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) * 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
JP2005281283A (ja) 2004-03-31 2005-10-13 Akira Matsumori ベンズイミダゾール系薬剤の併用医薬
WO2006085208A2 (fr) 2005-02-11 2006-08-17 Ranbaxy Laboratories Limited Formes galeniques solides stables d'amlodipine et de benazepril
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ,インク. 複数の活性セグメントを含む薬剤の錠剤
PL2120878T3 (pl) 2007-02-09 2015-01-30 Alphapharm Pty Ltd Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
FR2917975B1 (fr) * 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
WO2010055119A2 (fr) 2008-11-17 2010-05-20 Novartis Ag Composition pharmaceutique comprenant du pimobendane
WO2010097501A2 (fr) 2009-02-26 2010-09-02 Orion Corporation Traitement combiné
WO2011111066A2 (fr) 2010-03-12 2011-09-15 Connexios Life Sciences Pvt. Ltd. Composition et ses utilisations
EP2793866B2 (fr) 2011-12-21 2023-10-25 Elanco Tiergesundheit AG Comprimé bicouche comprenant du chlorhydrate de bénazépril et du pimobendane

Also Published As

Publication number Publication date
HUE035830T2 (en) 2018-05-28
CA2858941A1 (fr) 2013-06-27
ES2560052T5 (es) 2024-06-07
PT3034071T (pt) 2018-01-19
RU2014129508A (ru) 2016-02-10
JP6148252B2 (ja) 2017-06-14
AU2012357795B2 (en) 2017-04-06
PL2793866T5 (pl) 2023-12-04
CA2858941C (fr) 2020-11-10
CN104010632A (zh) 2014-08-27
PL3034071T3 (pl) 2018-05-30
EP2793866B2 (fr) 2023-10-25
EP3034071A1 (fr) 2016-06-22
WO2013092673A3 (fr) 2013-09-12
EP2793866B1 (fr) 2015-11-25
WO2013092673A2 (fr) 2013-06-27
NZ625506A (en) 2016-10-28
HUE028579T2 (en) 2016-12-28
EP3034071B1 (fr) 2017-12-06
RS54475B1 (sr) 2016-06-30
BR112014014896A2 (pt) 2017-06-13
PL2793866T3 (pl) 2016-05-31
SI2793866T1 (sl) 2016-01-29
EP3320894A1 (fr) 2018-05-16
AU2012357795A1 (en) 2014-06-19
DK2793866T4 (da) 2023-12-04
EP2793866A2 (fr) 2014-10-29
MX365621B (es) 2019-06-07
US10874618B2 (en) 2020-12-29
US20140363505A1 (en) 2014-12-11
CO6970601A2 (es) 2014-06-13
CL2014001534A1 (es) 2014-09-05
MX2014007700A (es) 2014-08-21
DK3034071T3 (en) 2018-01-22
CN104010632B (zh) 2016-08-24
ES2656412T3 (es) 2018-02-27
HRP20151347T1 (hr) 2016-01-01
CY1117086T1 (el) 2017-04-05
ES2560052T3 (es) 2016-02-17
JP2015506337A (ja) 2015-03-02
DK2793866T3 (en) 2016-02-15

Similar Documents

Publication Publication Date Title
BR112013022641A2 (fr)
BR112013027245A2 (fr)
BR112013024383A2 (fr)
BR112013023185A2 (fr)
BR112013022995A2 (fr)
BR112013017670A2 (fr)
BR112013027830A2 (fr)
AP3853A (fr)
BR112013023927A2 (fr)
BR112013027452A2 (fr)
BR112013024365A2 (fr)
BR112013027121A2 (fr)
AP2016009466A0 (fr)
BR112013024588A2 (fr)
BR112013032380A2 (fr)
BR112013032377A2 (fr)
BR112013027836A2 (fr)
BR112013018949A2 (fr)
BR112013027761A2 (fr)
BR112013021637A2 (fr)
BR112013023266A2 (fr)
BR112013032392A2 (fr)
BR112013025487A2 (fr)
BR112013017878A2 (fr)
NO3034071T3 (fr)